BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17481662)

  • 41. Botulinum toxin A and the cutaneous nociception in humans: a prospective, double-blind, placebo-controlled, randomized study.
    Blersch W; Schulte-Mattler WJ; Przywara S; May A; Bigalke H; Wohlfarth K
    J Neurol Sci; 2002 Dec; 205(1):59-63. PubMed ID: 12409185
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Peptide-mediated transdermal delivery of botulinum neurotoxin type A reduces neurogenic inflammation in the skin.
    Carmichael NME; Dostrovsky JO; Charlton MP
    Pain; 2010 May; 149(2):316-324. PubMed ID: 20223589
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential effect of Incobotulinumtoxin A on pain, neurogenic flare and hyperalgesia in human surrogate models of neurogenic pain.
    Diener SA; Breimhorst M; Vogt T; Krämer HH; Drummond PD; Geber C; Birklein F
    Eur J Pain; 2017 Sep; 21(8):1326-1335. PubMed ID: 28440002
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intraprostatic botulinum toxin a injection inhibits cyclooxygenase-2 expression and suppresses prostatic pain on capsaicin induced prostatitis model in rat.
    Chuang YC; Yoshimura N; Huang CC; Wu M; Chiang PH; Chancellor MB
    J Urol; 2008 Aug; 180(2):742-8. PubMed ID: 18554636
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Areas of capsaicin-induced secondary hyperalgesia and allodynia are reduced by a single chiropractic adjustment: a preliminary study.
    Mohammadian P; Gonsalves A; Tsai C; Hummel T; Carpenter T
    J Manipulative Physiol Ther; 2004; 27(6):381-7. PubMed ID: 15319760
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanically induced axon reflex and hyperalgesia in human UV-B burn are reduced by systemic lidocaine.
    Koppert W; Brueckl V; Weidner C; Schmelz M
    Eur J Pain; 2004 Jun; 8(3):237-44. PubMed ID: 15109974
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential effect of intravenous S-ketamine and fentanyl on atypical odontalgia and capsaicin-evoked pain.
    Baad-Hansen L; Juhl GI; Jensen TS; Brandsborg B; Svensson P
    Pain; 2007 May; 129(1-2):46-54. PubMed ID: 17088020
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interaction between histamine-induced itch and experimental muscle pain.
    Wasner G; Schwarz K; Schattschneider J; Binder A; Jensen TS; Baron R
    Eur J Pain; 2004 Jun; 8(3):179-85. PubMed ID: 15109968
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of the new H1-antagonist ReN1869 on capsaicin-induced hyperalgesia in human skin/Human phase-I trial using somatosensory evoked potentials induced by a CO2 laser.
    Schaffler K; Seibel K; Thomsen M; Edwards M
    Arzneimittelforschung; 2004; 54(3):187-91. PubMed ID: 15112866
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evoked pain in the motor endplate region of the brachial biceps muscle: an experimental study.
    Qerama E; Fuglsang-Frederiksen A; Kasch H; Bach FW; Jensen TS
    Muscle Nerve; 2004 Mar; 29(3):393-400. PubMed ID: 14981739
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intraprostatic capsaicin injection as a novel model for nonbacterial prostatitis and effects of botulinum toxin A.
    Chuang YC; Yoshimura N; Wu M; Huang CC; Chiang PH; Tyagi P; Chancellor MB
    Eur Urol; 2007 Apr; 51(4):1119-27. PubMed ID: 17141941
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Central origin of the antinociceptive action of botulinum toxin type A.
    Bach-Rojecky L; Lacković Z
    Pharmacol Biochem Behav; 2009 Dec; 94(2):234-8. PubMed ID: 19732788
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of secondary hyperalgesia produced by topical capsaicin jelly--a new experimental tool for pain research.
    Harding LM; Murphy A; Kinnman E; Baranowski AP
    Eur J Pain; 2001; 5(4):363-71. PubMed ID: 11743702
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diphenyl diselenide attenuates acute thermal hyperalgesia and persistent inflammatory and neuropathic pain behavior in mice.
    Savegnago L; Jesse CR; Pinto LG; Rocha JB; Nogueira CW
    Brain Res; 2007 Oct; 1175():54-9. PubMed ID: 17888416
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Residual spinothalamic tract pathways predict development of central pain after spinal cord injury.
    Wasner G; Lee BB; Engel S; McLachlan E
    Brain; 2008 Sep; 131(Pt 9):2387-400. PubMed ID: 18669485
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dissociable neural activity to self- vs. externally administered thermal hyperalgesia: a parametric fMRI study.
    Mohr C; Leyendecker S; Helmchen C
    Eur J Neurosci; 2008 Feb; 27(3):739-49. PubMed ID: 18279326
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A prospective randomized controlled study of the role of botulinum toxin in whiplash-associated disorder.
    Carroll A; Barnes M; Comiskey C
    Clin Rehabil; 2008 Jun; 22(6):513-9. PubMed ID: 18511531
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Different roles of spinal p38 and c-Jun N-terminal kinase pathways in bee venom-induced multiple pain-related behaviors.
    Cao FL; Liu MG; Hao J; Li Z; Lu ZM; Chen J
    Neurosci Lett; 2007 Oct; 427(1):50-4. PubMed ID: 17923327
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Double stimulation of tiny skin areas in human subjects increases the number of C- and Adelta-fiber responses.
    Weiss T; Miltner WH
    Neurosci Lett; 2005 Oct; 386(3):165-9. PubMed ID: 15992995
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Secondary tactile hypoesthesia: a novel type of pain-induced somatosensory plasticity in human subjects.
    Magerl W; Treede RD
    Neurosci Lett; 2004 May; 361(1-3):136-9. PubMed ID: 15135912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.